Human iPSC Tri-Culture for Alzheimer’s Disease Poster
iPSC-Based Parkinson’s Disease Model Poster
iPSC Platforms for RNA Therapeutics Efficacy & In Vivo Toxicity Poster
iPSC Platform for RNA Therapeutics Poster
Ncyte® NHP-C vCardiomyocytes Poster
Ncyte® Plate-ready vCardiomyocytes Fact Sheet
Scalable, Consistent Cardiotoxicity & Preclinical Safety Studies
Advancing High-Throughput Cardiac Screening With Physiologically Relevant 3D ...
The Evolving Role of Non-Human Primates in Preclinical Research: Challenges, Shifts ...
Scientific Poster: Advancing Cardiovascular Drug Discovery With iPSC-Derived 3D ...
Advancing Gene Therapy Potency Testing with iPSC-Based Systems
Revolutionizing Cardiac Safety Assessment with NHP Cardiomyocytes
A Reduction in Animal Testing Stems From Ncardia
See How Ncardia Is Supporting the Shift From Animal Models With iPSC Technology
Advancing High-Throughput Cardiac Screening With Physiologically Relevant 3D ...
.png)
Breaking New Ground in ALS Research
Ready-to-use iPSC-based assay to screen ALS therapeutics
Webinar: Human Hematopoietic Stem Cell Manufacturing from iPSCs
Catalyzing the Discovery of New Treatments for Proteinopathies
Mastering Consistency and Quality in iPSC-Derived Cell Manufacturing to Propel ...
Press release: Ncardia Launches First-of-Its-Kind iPSC-Derived Non-Human Primate ...
The FDA Is Moving Past Animal Testing. Here’s How Ncardia Helps Make It Happen
Press release: Ncardia launches Ncyte® Microglia
Press release: Ncardia launches Ncyte® Heart in a Box
Press release: Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target ...
Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening and Selection ...
Ncardia Acquires STAR-CRISPR Technology for Advanced Gene Editing of iPSCs
Unveiling Ncardia's Path to Innovation and Growth
The Urgent Need for Reliable Cell Models in ALS Research
Ncardia @ ASGCT 24: The latest updates from Baltimore